Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Return on Assets: 2020-2025

Historic Return on Assets for Revolution Medicines (RVMD) over the last 6 years, with Sep 2025 value amounting to -0.41%.

  • Revolution Medicines' Return on Assets fell 9.00% to -0.41% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.41%, marking a year-over-year decrease of 9.00%. This contributed to the annual value of -0.26% for FY2024, which is 4.00% up from last year.
  • According to the latest figures from Q3 2025, Revolution Medicines' Return on Assets is -0.41%, which was down 21.21% from -0.34% recorded in Q2 2025.
  • Revolution Medicines' Return on Assets' 5-year high stood at -0.18% during Q2 2021, with a 5-year trough of -0.41% in Q3 2025.
  • Moreover, its 3-year median value for Return on Assets was -0.28% (2025), whereas its average is -0.30%.
  • Per our database at Business Quant, Revolution Medicines' Return on Assets dropped by 16bps in 2022 and then increased by 7bps in 2023.
  • Quarterly analysis of 5 years shows Revolution Medicines' Return on Assets stood at -0.25% in 2021, then declined by 5bps to -0.30% in 2022, then climbed by 2bps to -0.29% in 2023, then rose by 1bps to -0.28% in 2024, then declined by 9bps to -0.41% in 2025.
  • Its Return on Assets stands at -0.41% for Q3 2025, versus -0.34% for Q2 2025 and -0.28% for Q1 2025.